Abatacept provides clinical benefits in rheumatoid arthritis (RA) patients who previously demonstrated a lack of response or no response to one or more anti-TNF therapies

被引：0
|
作者：
Keystone, E.
Aranda, R.
Becker, J-C
Covucci, A.
Genovese, M. C.
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Bristol Myers Squibb Co, Princeton, NJ USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2007年 / 34卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1630 / 1630
页数：1
相关论文
共 50 条
  • [1] Abatacept provides clinical benefits in rheumatoid arthritis (RA) patients who previously demonstrated a lack of response or no response to one or more anti-TNF therapies.
    Keystone, E.
    Aranda, R.
    Becker, J-C
    Covucci, A.
    Genovese, M. C.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S406 - S406
  • [2] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY BY NUMBER OF PRIOR ANTI-TNF THERAPIES USED
    Schiff, M.
    Le Bars, M.
    Gaillez, C.
    Wu, G.
    Poncet, C.
    Genovese, M. C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S29 - S30
  • [3] Time to treatment response with abatacept in patients with RA and an inadequate response to Anti-TNF therapy
    Schiff, M.
    Dougados, M.
    Le Bars, M.
    Lafosse, C.
    Koncz, T.
    Genovese, M. C.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S307 - S308
  • [4] Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNFα therapies
    Keystone, E. C.
    Burmester, G. R.
    Furie, R. A.
    Loveless, J. E.
    Emery, P.
    Isaacs, J.
    Jubb, R.
    Dawes, P.
    Cravets, M. W.
    Magrini, F.
    RHEUMATOLOGY, 2006, 45 : I46 - I47
  • [5] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy
    Genovese, MC
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 767 - 768
  • [6] Clinical outcomes in patients after one or multiple anti-TNF therapies in rheumatoid arthritis
    Glass, Roberta J.
    Shadick, Nancy A.
    Cui, Jing
    Maher, Nancy
    Weinblatt, Michael
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S526 - S526
  • [7] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Hirabara, Shinya
    Takahashi, Nobunori
    Fukaya, Naoki
    Miyake, Hiroyuki
    Yabe, Yuichiro
    Kaneko, Atsushi
    Ito, Takayasu
    Oguchi, Takeshi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Sugiura, Fumiaki
    Hayashi, Masatoshi
    Funahashi, Koji
    Hanabayashi, Masahiro
    Asai, Shuji
    Ishiguro, Naoki
    Kojima, Toshihisa
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1247 - 1254
  • [8] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Shinya Hirabara
    Nobunori Takahashi
    Naoki Fukaya
    Hiroyuki Miyake
    Yuichiro Yabe
    Atsushi Kaneko
    Takayasu Ito
    Takeshi Oguchi
    Daihei Kida
    Yuji Hirano
    Takayoshi Fujibayashi
    Fumiaki Sugiura
    Masatoshi Hayashi
    Koji Funahashi
    Masahiro Hanabayashi
    Shuji Asai
    Naoki Ishiguro
    Toshihisa Kojima
    Clinical Rheumatology, 2014, 33 : 1247 - 1254
  • [9] Response to pneumococcal vaccine in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy treated with abatacept in the arrive trial
    Schiff, M.
    Kaell, A.
    Tay, L.
    Vratsanos, G.
    Bahrt, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 437 - 437
  • [10] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy -: Comment
    Emery, P
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 768 - 768
12345